Addex Therapeutics Ltd ADXN
NASDAQ
| 03/31/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -- | 174.52% |
| Total Depreciation and Amortization | -- | -- | -- | -- | 1,521.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -584.20% |
| Change in Net Operating Assets | -- | -- | -- | -- | -241.95% |
| Cash from Operations | -- | -- | -- | -- | 52.41% |
| Capital Expenditure | -- | -- | -- | -- | 70.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 102,820.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 96.25% |
| Issuance of Common Stock | -- | -- | -- | -- | -99.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | 47.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -98.03% |
| Cash from Financing | -- | -- | -- | -- | -99.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 93.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 196.68% |
| Net Change in Cash | -- | -- | -- | -- | 128.57% |